(Q33341914)
Statements
Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer (English)
Sridhar Mani
Charles M Rudin
Katie Kunkel
Jon T Holmlund
Richard S Geary
Hedy L Kindler